(Q44062588)

29 November 2017

Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism (English)

1 reference

29 November 2017

1 reference

7

Grazyna Hoser

1 reference

29 November 2017

1

Wojciech Feleszko

1 reference

29 November 2017

9

Marek Jakóbisiak

1 reference

29 November 2017

Grażyna Korczak-Kowalska

8

object named as

Grazyna Korczak-Kowalska

1 reference

29 November 2017

Izabela Młynarczuk

2

1 reference

29 November 2017

Dominika Olszewska

3

1 reference

29 November 2017

Ahmad Jalili

4

1 reference

29 November 2017

Tomasz Grzela

5

1 reference

29 November 2017

Witold Lasek

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

International Journal of Cancer

29 November 2017

1 reference

29 November 2017

100

1 reference

29 November 2017

1

1 reference

29 November 2017

111-118

1 reference

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

29 November 2017

1 reference

Current perspectives on statins

21 January 2018

1 reference

Inhibitors of Ras farnesyltransferases

21 January 2018

1 reference

Cell cycle-specific effects of lovastatin

21 January 2018

1 reference

Lovastatin induces apoptosis in malignant mesothelioma cells.

21 January 2018

1 reference

Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin.

21 January 2018

1 reference

Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells

21 January 2018

1 reference

Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor via inhibition of tumor-induced angiogenesis

21 January 2018

1 reference

Novel Ras antagonist blocks human melanoma growth

21 January 2018

1 reference

Tourniquet infusion chemotherapy for extremity in-transit lesions in malignant melanoma

21 January 2018

1 reference

Epirubicin has modest single-agent activity in head and neck cancer but limited activity in metastatic melanoma and colorectal cancer: phase II studies by the Eastern Cooperative Oncology Group

21 January 2018

1 reference

A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme

21 January 2018

1 reference

Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme a reductase and cell growth

21 January 2018

1 reference

Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac

21 January 2018

1 reference

In vitro antitumor activity of cerivastatin, a novel and potent HMG-CoA reductase inhibitor

21 January 2018

1 reference

Growth in use of statins after trials is not targeted to most appropriate patients

21 January 2018

1 reference

Protein prenylation: a mediator of protein-protein interactions

21 January 2018

1 reference

Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma

21 January 2018

1 reference

Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice

21 January 2018

1 reference

Re: Greying of America will foster new strategies in oncology

21 January 2018

1 reference

Effects of lovastatin on a human myeloma cell line: increased sensitivity of a multidrug-resistant subline that expresses the 170 kDa P-glycoprotein.

21 January 2018

1 reference

HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: lovastatin specifically targets P-glycoprotein-expressing cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10440

1 reference

29 November 2017

1 reference